Randomized clinical trials have consistently shown that TMS provides a clinically relevant benefit for patients with treatment-resistant depression.
Studies have revealed that TMS is more effective than placebo treatment in treating acute major depression in patients who have not responded to at least one medication.
It is consistent with the treatment guidelines of the American Psychiatric Association, the Canadian Network for Mood and Anxiety Treatments, and the Royal Australian and New Zealand College of Psychiatrists in supporting the use of TMS for treatment-resistant or refractory depression.
Patients with treatment-resistant depression who have tried antidepressants without success may be treated successfully with repetitive transcranial magnetic stimulation (TMS). Depression can be treated with this noninvasive technique in patients who have not responded to previous therapies.